Cornerstone Planning Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.3K Buy
389
+102
+36% +$6.96K ﹤0.01% 543
2026
Q1
$18.9K Hold
287
﹤0.01% 689
2025
Q4
$20.9K Sell
287
-1
-0.3% -$67 ﹤0.01% 576
2025
Q3
$18.6K Buy
288
+280
+3,500% +$18.6K ﹤0.01% 607
2025
Q2
$486 Sell
8
-13
-62% -$740 ﹤0.01% 1306
2025
Q1
$1.23K Buy
21
+13
+163% +$755 ﹤0.01% 1089
2024
Q4
$447 Buy
+8
New +$410 ﹤0.01% 1176
2023
Q3
Sell
-26
Closed -$938 1250
2023
Q2
$938 Buy
+26
New +$887 ﹤0.01% 1369
2022
Q4
$1.13K Buy
+22
New +$1.13K ﹤0.01% 1329

Other funds holding HALO

Cornerstone Planning Group's HALO Position: Q2 2026 in Review

Cornerstone Planning Group increased its Halozyme (HALO) stake by 36% in Q2 2026, buying an estimated $6.96K and bringing the position to 389 shares worth $30.3K. The position accounts for ﹤0.01% of the portfolio, ranked #543.

Cornerstone Planning Group first reported a position in HALO in Q4 2022 and has held it in 9 quarters since. 369 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Cornerstone Planning Group held 389 shares of Halozyme worth $30.3K as of Q2 2026.
  • Cornerstone Planning Group bought 102 Halozyme shares in Q2 2026, an estimated $6.96K.
  • Halozyme made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #543 holding.
  • Cornerstone Planning Group first reported a position in Halozyme in Q4 2022 and has held it in 9 quarters since.
  • 369 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.